Stephen Basso insider trades

Open-market stock purchases and sales by Stephen Basso, Chief Financial Officer at Innoviva, Inc, from SEC Form 4 filings since Jul 23, 2020.

Recent trades

DateStockTradeValue
May 20, 2026INVA Innoviva, IncSold (not open market)$12.4K
May 15, 2026INVA Innoviva, IncBought (not open market)—
May 4, 2026INVA Innoviva, IncBought (not open market)—
May 4, 2026INVA Innoviva, IncBought (not open market)—
Feb 20, 2026INVA Innoviva, IncSold (not open market)$29.1K
Nov 20, 2025INVA Innoviva, IncSold (not open market)$5K
Nov 15, 2025INVA Innoviva, IncBought (not open market)—
Nov 3, 2025INVA Innoviva, IncBought (not open market)$500K

Companies traded

  • INVA Innoviva, Inc: other filings, last May 20, 2026
  • INZY Inozyme Pharma, Inc: other filings, last Mar 24, 2021

Get free alerts when Stephen Basso files a new trade →